Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/22527
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Perkins, AM | - |
dc.contributor.author | Ettinger, U | - |
dc.contributor.author | Weaver, K | - |
dc.contributor.author | Schmechtig, A | - |
dc.contributor.author | Schrantee, A | - |
dc.contributor.author | Morrison, PD | - |
dc.contributor.author | Sapara, A | - |
dc.contributor.author | Kumari, V | - |
dc.contributor.author | Williams, SCR | - |
dc.contributor.author | Corr, PJ | - |
dc.date.accessioned | 2021-04-12T09:56:57Z | - |
dc.date.available | 2013-06-11 | - |
dc.date.available | 2021-04-12T09:56:57Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Translational Psychiatry, 2013, 3 | en_US |
dc.identifier.issn | 2158-3188 | - |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/22527 | - |
dc.description.abstract | Clinically effective drugs against human anxiety and fear systematically alter the innate defensive behavior of rodents, suggesting that in humans these emotions reflect defensive adaptations. Compelling experimental human evidence for this theory is yet to be obtained. We report the clearest test to date by investigating the effects of 1 and 2mg of the anti-anxiety drug lorazepam on the intensity of threat-avoidance behavior in 40 healthy adult volunteers (20 females). We found lorazepam modulated the intensity of participants' threat-avoidance behavior in a dose-dependent manner. However, the pattern of effects depended upon two factors: type of threat-avoidance behavior and theoretically relevant measures of personality. In the case of flight behavior (one-way active avoidance), lorazepam increased intensity in low scorers on the Fear Survey Schedule tissuedamage fear but reduced it in high scorers. Conversely, in the case of risk-assessment behavior (two-way active avoidance), lorazepam reduced intensity in low scorers on the Spielberger trait anxiety but increased it in high scorers. Anti-anxiety drugs do not systematically affect rodent flight behavior; therefore, we interpret this new finding as suggesting that lorazepam has a broader effect on defense in humans than in rodents, perhaps by modulating general perceptions of threat intensity. The different patterning of lorazepam effects on the two behaviors implies that human perceptions of threat intensity are nevertheless distributed across two different neural streams, which influence effects observed on one-way or two-way active avoidance demanded by the situation. © 2013 Macmillan Publishers Limited. | en_US |
dc.description.sponsorship | MRC; Wellcome Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Nature | en_US |
dc.subject | anxiety | en_US |
dc.subject | fear | en_US |
dc.subject | flight | en_US |
dc.subject | human defense | en_US |
dc.subject | lorazepam | en_US |
dc.subject | risk assessment | en_US |
dc.title | Advancing the defensive explanation for anxiety disorders: Lorazepam effects on human defense are systematically modulated by personality and threat-type | en_US |
dc.type | Article | en_US |
dc.identifier.doi | http://dx.doi.org/10.1038/tp.2013.20 | - |
dc.relation.isPartOf | Translational Psychiatry | - |
pubs.publication-status | Published | - |
pubs.volume | 3 | - |
dc.identifier.eissn | 2158-3188 | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 735.2 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.